CDKN2B (encoding p15INK4b) acts as a tumor suppressor by promoting cell cycle arrest and senescence in the absence of CDKN2A, especially in pancreatic cancer (Krimpenfort et al, 2007; Tu et al, 2017). Here, CDKN2B is linked to pancreatic neoplasm.